Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Withdrawn 3Unknown 3Recruiting 3Terminated 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Conditions

Telangiectasis 1Rosacea 1Port-Wine Stain 1Hemangioma 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Interventional × Tomography, Optical Coherence × Clear all
NCT04336163 2024-01-30

Skin Imaging to Inform Laser Treatments

University of California, Irvine

Phase NA Terminated
55 enrolled 6 charts

Hemangioma, Rosacea, Telangiectasis, Port-Wine Stain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡